Connect with us


Sanjay Dutt diagnosed with stage 3 lung cancer, to fly to US for treatment | People News


Sanjay Dutt diagnosed with stage 3 lung cancer, to fly to US for treatment | People News

Actor Sanjay Dutt was on August 11 (Tuesday) diagnosed with lung cancer and will fly to the US for treatment. According to media reports, Dutt has been diagnosed with third stage (Stage-3) lung cancer.

According to sources, he is leaving for the US on Wednesday itself. When he was recently hospitalised, he was diagnosed with the ailment. He was discharged from the hospital after two days.

Earlier in the day, Dutt had said that he has taken a short break from work for medical treatment. In a social media post, he had said, “Hi, friends. I am taking a short break from work for some medical treatment. My family and friends are with me and I urge my well-wishers not to worry or unnecessarily speculate. With your love and good wishes, I will be back soon.” 

The 61-year-old actor was recently admitted to Mumbai’s Lilavati Hospital after he complained of breathlessness and uneasiness. He was also tested for coronavirus, the report of which was negative. Sanjay Dutt stayed in the hospital over the weekend and returned home on August 10 afternoon. 

On August 8 night, shortly after being hospitalised, he tweeted, “Just wanted to assure everyone that I’m doing well. I’m currently under medical observation and my COVID-19 report is negative. With the help and care of the doctors, nurses and staff at Lilavati hospital, I should be home in a day or two. Thank you for your well wishes and blessings.”

On the work front, Sanjay Dutt has several movies in the pipeline, including ‘Torbaaz’, ‘KGF: Chapter 2’, ‘Sadak 2’, ‘Bhuj: The Pride Of India’ and ‘Shamshera’.

‘Sadak 2’, the sequel to the 1991 hit of the same name, is his upcoming release. The film reunites Sanjay Dutt with Pooja Bhatt and filmmaker Mahesh Bhatt and also casts Alia Bhatt and Aditya Roy Kapur in pivotal roles. 

‘Sadak 2’ is slated to release on August 28.

Source link

Subscribe to the newsletter news

We hate SPAM and promise to keep your email address safe

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

To Top